LARSON KEITH R
LARSON KEITH R's purchase track record
LARSON KEITH R has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/24/2025 | ASTS | $50K | +23.1% | -12.9% | +6.2% |
| 12/10/2025 | ASTS | $99K | +11.6% | +10.5% | +5.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ASTS Shares Dip Amid Launch Delays and Whale Activity. AST SpaceMobile shares fell more than the broader market, with analysts pointing to recent launch schedule delays as a key factor. Whale activity in the communication services sector was also reported, adding pressure on the stock. The price is now close to its $56.65 support level, where it has found support many times.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Roche presents new Phase III data and FDA approval. Roche reported new one-year Phase III data for vamikibart in treating uveitic macular edema, a condition causing vision loss. Additionally, the FDA approved Tecentriq for adjuvant treatment of stage III colon cancer. These developments reflect ongoing progress in the company's clinical pipeline and regulatory approvals.
Transaction History
| NWPX | ▼ Sell | Open Market | 250 | $27K | 10/5/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $102K | 9/28/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $102K | 9/21/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $101K | 9/14/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $106K | 9/8/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 4 | $443 | 9/3/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 74 | $8K | 9/2/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,172 | $129K | 8/31/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,250 | $138K | 8/24/2026 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,250 | $145K | 8/17/2026 | View on chart |
| NWPX | ▲ Buy | Grant | 899 | $110K | 6/10/2026 | View on chart |
| ASTS | ▲ Buy | Open Market | 625 | $50K | 12/24/2025 | View on chart |
| ASTS | ▲ Buy | Open Market | 715 | $50K | 12/17/2025 | View on chart |
| ASTS | ▲ Buy | Open Market | 675 | $49K | 12/10/2025 | View on chart |
| NWPX | ▲ Buy | Grant | 2,166 | $85K | 6/12/2025 | View on chart |
| NWPX | ▲ Buy | Grant | 2,404 | $80K | 6/13/2024 | View on chart |
| NWPX | ▲ Buy | Grant | 2,537 | $75K | 6/22/2023 | View on chart |
| NWPX | ▲ Buy | Grant | 2,276 | $70K | 6/16/2022 | View on chart |
| ROG | ▲ Buy | Grant | 600 | $0 | 5/5/2022 | View on chart |
| NWPX | ▼ Sell | Open Market | 313 | $9K | 12/6/2021 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $30K | 11/29/2021 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $31K | 11/22/2021 | View on chart |
| NWPX | ▼ Sell | Open Market | 1,000 | $29K | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Yahoo Highlights NWPX as Small‑Cap Stock for Long‑Term Investors
Yahoo’s recent piece lists NWPX among small‑cap stocks that may appeal to long‑term investors. The company’s price is near a key support level at $108.58 and is showing a bollinger band breakdown and a 200‑day SMA touch, suggesting a potential consolidation phase. With a trailing P/E of 19.7 and analyst targets ranging from $95 to $130, the stock sits well within its 52‑week range of $49.25 to $152.03.
Yahoo Highlights NWPX as Small‑Cap Stock for Long‑Term Investors. Yahoo’s recent piece lists NWPX among small‑cap stocks that may appeal to long‑term investors. The company’s price is near a key support level at $108.58 and is showing a bollinger band breakdown and a 200‑day SMA touch, suggesting a potential consolidation phase. With a trailing P/E of 19.7 and analyst targets ranging from $95 to $130, the stock sits well within its 52‑week range of $49.25 to $152.03.